->

I-Tag: Seagen Inc

Ikhaya / Unyaka Omisiwe

OG-Tukysa-logo
, , , , ,

Ukugunyazwa okusheshisiwe kunikezwa yi-FDA ku-tucatinib ene-trastuzumab yomdlavuza we-colorectal

NgoFebhuwari 2023, i-Food and Drug Administration (FDA) yasheshisa ukugunyazwa kwe-tucatinib (Tukysa, Seagen Inc.) kanye ne-trastuzumab yokwelashwa kwe-RAS wild-type HER2-positive colorectal cancer osusabalele noma ongakwazi ukuphinda ulashwe.

I-Brentuximab vedotin
, , ,

I-Brentuximab vedotin ivunywe yi-FDA ngokuhlanganiswa ne-chemotherapy yeziguli zezingane ezine-classical Hodgkin lymphoma

Novemba 2022: Inhlanganisela ye-doxorubicin, i-vincristine, i-etoposide, i-prednisone, ne-cyclophosphamide ene-brentuximab vedotin (Adcetris, Seagen, Inc.) igunyazwe i-Food and Drug Administration ukuze isetshenziswe ezinganeni.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton